13:30 |
0448.
|
Background Parenchymal
Enhancement (BPE) in Healthy Subjects and Breast Cancer
Patients: A Quantitative Evaluation and Comparison with
Diffusion-weighted Imaging
Gene Young Cho1,2, Linda Moy3,
Scott DeGregorio3, Sungheon Kim1,
Melanie Moccaldi3, Jane Kwon1,
Steven Baete1, Daniel K Sodickson1,
and Eric E Sigmund1
1Radiology, NYU School of Medicine - Schwartz
Center for Biomedical Imaging, New York, NY, United
States, 2NYU
Sackler Institute of Biomedical Science, New York, NY,
United States, 3Radiology,
NYU School of Medicine, New York, NY, United States
Recent studies have used MRI biomarkers such as
background parenchymal enhancement (BPE) and apparent
diffusion coefficient (ADC) to correlate with prognostic
factors of breast cancer and predict cancer odds. An
increased BPE correlates significantly with higher odds
ratios for developing breast cancer. In this study, BPE
was measured from a cohort of healthy controls and
breast cancer patients using dynamic contrast enhanced
MRI. BPE values were compared between controls and
patients, and with diffusion metrics of fibroglandular
tissue (FGT) and in the patient lesions. Implications
for the biophysical underpinnings of BPE and its
interpretation are considered.
|
13:42 |
0449. |
Differentiation between
Intermingled and Central Type Breast Parenchymal Patterns
Using Quantitative 3D Morphology and Texture Analysis on
Segmented Dense Tissue
Peter T. Fwu1, Jeon-Hor. Chen1,2,
Siwa Chan3, Dah-Cherng Yeh4,
Chin-Kai Chang2, Julian Kao1,
Muqing Lin1, Orhan Nalcioglu1, and
Min-Ying L. Su1
1Center for Functional Onco-Imaging,
Department of Radiological Sciences, University of
California, Irvne, California, United States, 2Department
of Radiology, China Medical University Hospital,
Taichung, Taiwan, 3Department
of Radiology, Taichung Veterans General Hospital,
Taichung, Taiwan,4Department of Surgery,
Taichung Veterans General Hospital, Taichung, Taiwan
The purpose is to develop a quantitative method to
characterize the breast density pattern using 3D
morphology and texture analysis for investigating its
role in cancer risk prediction. Morphology is
characterized by circularity, convexity, and
irregularity; texture is characterized by coefficient of
variation in signal intensity distribution and the GLCM
matrix. The ability of analyzed parameters to
differentiate between the central and the intermingled
breast density patterns is evaluated by the ROC
analysis. The results show that morphology parameters
can reach AUC of 0.95, texture parameters have a lower
AUC of 0.90, but combining them can yield AUC of 0.98.
|
13:54 |
0450.
|
Cyclooxygenase-2 mediates
changes in the extracellular matrix in triple negative
breast cancer
Samata M. Kakkad1, Ioannis Stasinopoulos1,
Marie-France Penet1, Arvind P. Pathak1,
Meiyappan Solaiyappan1, and Zaver M.
Bhujwalla1
1JHU ICMIC Program, Russell H. Morgan
Department of Radiology and Radiological Science, Johns
Hopkins University School of Medicine, Baltimore, MD,
United States
COX-2 is a critically important mediator of inflammation
that significantly influences tumor angiogenesis,
invasion and metastasis. Here, we investigated the role
of COX-2 in altering structure and function of the
extracellular matrix (ECM) using MRI and second harmonic
generation (SHG) imaging of tumors derived from triple
negative MDA-MB-231 breast cancer cells and a derived
clone stably expressing shRNA downregulating COX-2. MRI
of albumin-GdDTPA was used to characterize
macromolecular fluid transport and SHG imaging to
quantify collagen I fiber morphology. COX-2
downregulation decreased fibrillar collagen and altered
macromolecular fluid transport. These results identify
new roles for COX-2 in altering the ECM.
|
14:06 |
0451. |
3D Mapping of total
Choline in Human Breast Cancer Using High-Speed MR
Spectroscopic Imaging at 3T: Initial Experience during
Neoadjuvant Therapy
Stefan Posse1,2, Tongsheng Zhang1,
Melanie Royce3, Zoneddy Dayao3,
Susan Lopez4, Laurel Sillerud5,
Stephen Eberhardt6, Lesley Lomo7,
Sang-Joon Lee8, Ashwani Rajput9,
John Russell9, Linda Casey10, and
Patrick Bolan11
1Neurology, University of New Mexico,
Albuquerque, NM, United States, 2Electrical
and Computer Engineering, Physics and Astronomy,
University of New Mexico, Albuquerque, NM, United
States, 3Medical
Oncology, University of New Mexico, Albuquerque, NM,
United States, 4Clinical
Trials Office, University of New Mexico, Albuquerque,
NM, United States, 5Biochemistry,
University of New Mexico, Albuquerque, NM, United
States, 6Radiology,
University of New Mexico, Albuquerque, NM, United
States, 7Pathology,
University of New Mexico, Albuquerque, NM, United
States, 8Internal
Medicine, University of New Mexico, Albuquerque, NM,
United States, 9Surgery,
University of New Mexico, Albuquerque, NM, United
States, 10New
Mexico Cancer Center, Albuquerque, NM, United States, 11Center
for Magnetic Resonance Research, University of
Minnesota, Minneapolis, MN, United States
Eleven patients with biopsy-confirmed, infiltrating
ductal carcinoma were studied at 3T using 3D lipid
suppressed Proton-Echo-Planar-Spectroscopic-Imaging
(PEPSI) with a 10 min scan protocol and 1 cc voxel size.
Strongly elevated tCho with mean concentrations between
0.3 and 4.1 mmol/kg was measured in 8 of the 11 patients
with single and multi-centric enhancing lesions.
Decreases in tCho concentration and number of voxels
with detectable tCho were measured in 3 patients who
underwent neoadjuvant therapy. An increase was measured
in one patient. At TE 60 ms an additional resonance was
detected that was elevated in enhancing lesions and
tentatively assigned to Taurine.
|
14:18 |
0452. |
Mean Intracellular
Water Molecule Lifetime: Another Useful Breast DCE-MRI
Biomarker?
Wei Huang1, Xin Li1, Luminita A
Tudorica1, Karen Y Oh1, Sunitha B
Thakur2, Elizabeth A Morris2, Yiyi
Chen1, Nicole Roy1, Mark D Kettler1,
Jason A Koutcher2, and Charles S Springer1
1Oregon Health & Science University,
Portland, Oregon, United States, 2Memorial
Sloan Kettering Cancer Center, New York, New York,
United States
157 patients with 172 suspicious breast lesions
underwent research DCE-MRI prior to biopsies. DCE-MRI
time-course data were subjected to both Standard model
(SM) and Shutter-Speed Model (SSM) analyses. Though not
a good diagnostic biomarker, the mean intracellular
water molecule lifetime, ôi, derived only with the SSM,
was significantly smaller in malignant compared to
benign lesions. ôi was also inversely correlated with SM
and SSM Ktrans. The inverse relationships of ôi with
cellular metabolic activity and Ktrans indicate its
potential use for detection of hypoxia/necrosis and
evaluation of breast cancer response to therapy.
|
14:30 |
0453. |
Thin slice high resolution
breast DWI at 3T (RESOLVE): increased separation of benign
from malignant tumors among BI-RADS 4/5 lesions
Dorota Jakubowski Wisner1, Nathan Rogers2,
Vibhas Deshpande3, Gerhard Laub3,
David Porter4, Bonnie Joe1, and
Nola Hylton1
1Radiology, University of California, San
Francisco, San Francisco, CA, United States, 2Radiology,
University of California, San Francisco, San Francisco,
California, United States, 3Siemens
Medical Solutions USA, Inc., San Francisco, CA, United
States, 4Siemens
Medical Solutions USA, Inc., Erlangen, Germany
This study compares ADC values obtained by thin-slice
RESOLVE (a readout segmented diffusion technique) to
typical EPI diffusion imaging at 3T, as tested on
suspicious breast MRI lesions prior to biopsy. We found
that among malignant lesions, RESOLVE demonstrates lower
mean ADC values, increasing separation between benign
and malignant lesions.
|
14:42 |
0454. |
Intravoxel Incoherent
Motion in Breast Lesions at 3 Tesla
Sunitha Thakur1,2, Louisa Bokacheva1,
Jennifer Kaplan2, Merlin Gnanasigamani2,
Gregory Nyman2, and Elizabeth Morris2
1Department of Medical Physics, Memorial
Sloan-Kettering Cancer Center, New York, New York,
United States, 2Department
of Radiology, Memorial Sloan-Kettering Cancer Center,
New York, New York, United States
Thirty eight patients with breast cancer, suspicious
lesions or family history of disease were studied with
multiple b-value diffusion-weighted MRI at 3 T. The
intravoxel incoherent motion (IVIM) effect was observed
in 11/13 of malignant lesions, in 1/8 benign lesion and
in none of the 17 normal fibroglandular tissue regions
of interest. In malignant lesions, the mean vascular
fraction was 0.16 0.04
and the pseudodiffusion coefficient was (8.5 2.5)x10 -3 mm 2/s.
The IVIM effect in breast lesions is difficult to
quantify reliably, but may add confidence in
discrimination malignant lesions from benign lesions.
|
14:54 |
0455.
|
Assessment of dynamic
range in dynamic contrast-enhanced breast examinations
Araminta E. W. Ledger1, Marco Borri1,
Maria Schmidt1, Romney Pope2,
Erica Scurr1, Toni Wallace1,
Cheryl Richardson2, Marianne Usher2,
Steven Allen2, Nandita deSouza1,
and Martin O. Leach1
1CR-UK and EPSRC Cancer Imaging Centre,
Institute of Cancer Research and Royal Marsden NHS
Foundation Trust, Sutton, Surrey, United Kingdom,2Department
of Radiology, Royal Marsden Hospital, Sutton, Surrey,
United Kingdom
The classification of enhancement curves in dynamic
contrast-enhanced (DCE) breast examinations requires
image intensity approximately proportional to contrast
agent concentration. We propose to evaluate the dynamic
range in breast DCE retrospectively, by considering the
enhancement of the internal mammary artery. This method
was validated by comparing clinical examinations
obtained with five different protocols (flip angles 10°,
14° and 18°, radial or linear k-space sampling).
Significant differences were found between groups of
7-10 patients, in agreement with expected behaviour
(greater dynamic range at higher flip angles, reduction
in dynamic range for radial sampling protocols).
Retrospective assessment is therefore a viable approach.
|
15:06 |
0456. |
High Spatio-temporal
Resolution Breast Dynamic Contrast Enhanced MRI at 3T
Manojkumar Saranathan1, Dan W Rettmann2,
Brian A Hargreaves1, Jafi Lipson1,
and Bruce Daniel1
1Radiology, Stanford University, Stanford,
CA, United States, 2Global
Applied Science Laboratory, GE Healthcare, Rochester,
MN, United States
Dynamic-contrast enhanced (DCE) MRI is the primary
approach for clinical breast imaging but is beset by the
need for both high spatial and high temporal resolution
[1-2], often resulting in suboptimal compromises. High
temporal resolution is required for quantitative
pharmacokinetic modeling whereas high spatial resolution
is necessary for clear delineation of tumor morphology.
We present clinical results from 20 patients of a new
variable spatio-temporal resolution technique that
seamlessly switches between the high temporal and high
spatial resolution modes. Bilateral coverage with
0.9x0.9x1.2 mm spatial resolution was achieved, with the
two modes having a temporal resolution of ~9s and ~120s
respectively
|
15:18 |
0457. |
The Utility of Sweep
Imaging with Fourier Transform (SWIFT) in breast cancer.
Curtis Andrew Corum1, Andrew Babcock2,
Djaudat Idiyatullin1, Angela L.
Styczynski-Snyder1, Diane Hutter1,
Lenore Everson2, Michael Nelson2,
and Michael Garwood1
1CMRR, Radiology, Medical Shcool, University
of Minnesota, Minneapolis, MN, United States, 2Radiology,
Medical Shcool, University of Minnesota, Minneapolis,
MN, United States
This paper is a feasibility study of SWeep Imaging with
Fourier Transform (SWIFT) to detect breast pathology. An
advantage of SWIFT is that the same scan data can be
formatted into hight temporal resolution DCE and high
spatial resolution morphological images. Three patients
who underwent SWIFT imaging after clinical suspicion of
breast pathology, but prior to biopsy, are presented.
The following pathology was identified: ductal carcinoma
in situ, fibroadenoma, and infiltrating ductal
carcinoma. SWIFT MRI shows benign and malignant features
similar to clinical DCE MRI and offers numerous
advantages. Benefits include faster imaging with
excellent spatial and temporal resolution, with reduced
T2* effects.
|
|